Seitz Stefanie, Buchholz Holger, Rebeyka Ivan, Ross David, West Lori, Urschel Simon
Department of Pediatrics, Stollery Children's Hospital, University of Alberta, Edmonton, AB, Canada.
Transpl Int. 2014 Jul;27(7):e54-7. doi: 10.1111/tri.12294. Epub 2014 Mar 29.
A girl received an ABO-incompatible heart transplantation (ABOiHTx) at the age of 3.5 years for failed univentricular palliation with protein-losing enteropathy (PLE). She was born with a hypoplastic left heart syndrome and underwent multistage palliation to a Fontan circulation at 2½ years of age. After the Fontan surgery, she developed PLE, necessitating a Fontan revision, followed by a Fontan takedown and eventually HTx, which was performed with a blood group B heart into an O recipient. Right ventricular (RV) failure secondary to increased pulmonary vascular resistance (PVR) evolved immediately after HTx. A temporary right ventricular assist device (RVAD) was implanted and later switched to a pneumatic pulsatile RVAD. With the adaption of PVR on the RVAD, the PLE resolved and the RVAD was explanted. In the following 12 months, she developed multiple relapses of PLE which eventually resolved after exchange of the calcineurin inhibitor.
一名3.5岁女孩因单心室姑息治疗失败合并蛋白丢失性肠病(PLE)接受了ABO血型不相容心脏移植(ABOiHTx)。她出生时患有左心发育不全综合征,2.5岁时接受了多阶段姑息治疗,建立了Fontan循环。Fontan手术后,她出现了PLE,需要进行Fontan翻修术,随后进行Fontan拆除术,最终接受了心脏移植,将B血型心脏植入O型受体。心脏移植后立即出现了因肺血管阻力(PVR)增加导致的右心室(RV)衰竭。植入了临时右心室辅助装置(RVAD),后来换成了气动搏动性RVAD。随着PVR在RVAD上的适应,PLE得到缓解,RVAD被取出。在接下来的12个月里,她多次复发PLE,最终在更换钙调神经磷酸酶抑制剂后得到缓解。